Continue
By using our website you accept our cookies policy.Find out more

Boosting research efforts for coeliac disease

Posted on 17/05/2018

Coeliac UK's research fund aims to change the future for people with coeliac disease and gluten related autoimmune conditions.

Coeliac UK, the largest independent charity for people who need to live gluten free, has launched a research fund and accompanying fundraising appeal, aiming to raise £5 million to change the future for people with coeliac disease and gluten related autoimmune conditions.

The research appeal is being headed up by Coeliac UK’s patron, actor Caroline Quentin who was diagnosed with the autoimmune disease three years ago. It will boost research efforts into key areas identified and agreed by patients, carers and healthcare professionals.

With the charity celebrating its 50th anniversary this year, there is a greater urgency to find better answers to the disease, which has links to other autoimmune conditions such as Type 1 diabetes and autoimmune thyroid disease and still relies on the gluten free diet as its only treatment.

Sarah Sleet, chief executive of Coeliac UK said:

“It is possible through further research, that finding the answers to coeliac disease could enable answers to other devastating autoimmune conditions such as Type 1 diabetes. With more people being diagnosed with coeliac disease each year and with new health complications emerging, it is critical that we make the commitment now to change the status quo and make coeliac disease research everyone’s priority.”

The Fund has already received an injection of £500k from Innovate UK, the UK’s innovation agency, which in addition to £250k from the charity, will support a new research competition. Match funding will draw in a further £250k from industry making the first £1 million available from the Fund.

Dr Ian Campbell, Interim Executive Chair for Innovate UK said:

“It’s fantastic to be working with charities such as Coeliac UK to promote innovations that will have a real, positive impact on people’s lives.”

Coeliac UK has already committed over £2 million to research projects since 2005 including ground breaking discoveries such as identifying genes associated with coeliac disease and other autoimmune conditions related to gluten. It has also funded research towards a vaccine to restore immune tolerance to gluten.

Ms Sleet added:

“50 years ago little was known about coeliac disease and the gluten free diet, bread used to come in a tin and people wrongly thought children would grow out of the autoimmune disease. Fast forward to today and both the disease and the diet are firmly on the worldwide map and 150,000 diagnosed people in the UK now live a better way of life thanks to improved recognition and diagnosis. However, half a million people remain undiagnosed and we need more support to help them get diagnosed and managing their condition with a gluten free diet. But, we also know that there needs to be a more permanent solution to this complex disease so we are boosting our research efforts and awareness raising as part of our 50th anniversary activities.” 

You can find out more about Coeliac UK’s Research Fund here.

Related interests:

Related Content

Shaping the future of precision medicine
KTN, on behalf of UK Research and Innovation, is holding a briefing event on 31 May in London for a new Collaborative R&D funding opportunity.
Recognising excellence in the application of chemical sciences to the study of food
Nominations are now open for the Royal Society of Chemistry's Food Group Junior Medal.
Trends and potential breakthroughs in food and nutrition security
FIT4FOOD2030 is conducting a survey on trends, cases and potential breakthroughs in research and innovation.